BWP
GSK icon

BSW Wealth Partners’s GSK GSK Stock Holding History

BSW Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Sell
9,689
-757
-7% -$40K 0.06% 182
2026
Q1 		$577K Sell
10,446
-613
-6% -$33.2K 0.07% 163
2025
Q4 		$542K Sell
11,059
-158
-1% -$7.37K 0.07% 170
2025
Q3 		$484K Buy
+11,217
New +$438K 0.06% 179
2024
Q4 		– Sell
-5,453
Closed -$223K – 320
2024
Q3 		$223K Buy
+5,453
New +$223K 0.03% 274
2024
Q1 		– Sell
-6,454
Closed -$239K – 307
2023
Q4 		$239K Buy
+6,454
New +$232K 0.05% 235
2023
Q3 		– Sell
-6,589
Closed -$235K – 262
2023
Q2 		$235K Buy
6,589
+244
+4% +$8.75K 0.05% 226
2023
Q1 		$226K Buy
6,345
+316
+5% +$11.1K 0.05% 275
2022
Q4 		$212K Sell
6,029
-3,197
-35% -$106K 0.05% 271
2022
Q3 		$272K Sell
9,226
-452
-5% -$17.1K 0.07% 200
2022
Q2 		$527K Buy
9,678
+985
+11% +$54.4K 0.13% 112
2022
Q1 		$473K Buy
8,693
+811
+10% +$44K 0.12% 128
2021
Q4 		$435K Buy
7,882
+496
+7% +$25.8K 0.11% 138
2021
Q3 		$353K Buy
+7,386
New +$371K 0.1% 147

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BSW Wealth Partners's GSK Position: Q2 2026 in Review

BSW Wealth Partners reduced its GSK (GSK) stake by 7.2% in Q2 2026, selling an estimated $40K and leaving 9,689 shares worth $508K. The position accounts for 0.06% of the portfolio, ranked #182.

BSW Wealth Partners first reported a position in GSK in Q3 2021 and has held it in 14 quarters since. The position peaked at $577K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • BSW Wealth Partners held 9,689 shares of GSK worth $508K as of Q2 2026.
  • BSW Wealth Partners sold 757 GSK shares in Q2 2026, an estimated $40K.
  • GSK made up 0.06% of BSW Wealth Partners's portfolio in Q2 2026, its #182 holding.
  • BSW Wealth Partners first reported a position in GSK in Q3 2021 and has held it in 14 quarters since.
  • BSW Wealth Partners's GSK position peaked at $577K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.